Source: International Congress 2018 – Therapeutic breakthroughs Year in Review
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
N. Maskell (Bristol (Avon), United Kingdom). Pleural disease (with a focus on malignant pleural disease). International Congress 2018 – Therapeutic breakthroughs Year in Review

Member's Comments

No comment yet.

Related content which might interest you: Pleural disease Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 Malignant pleural disease Source: Annual Congress 2012 - PG16 ERS/ACCP joint course on diagnostic and management strategies for pleural disorders Year: 2012 Pleural effusion as a presentation of Waldenström disease Source: Eur Respir J 2005; 26: Suppl. 49, 74s Year: 2005 Multidisciplinary approach to connective tissue disease (CTD) related pleural effusions Source: International Congress 2018 – Pleural interventions Year: 2018 Metastatic pleural effusions (mpes) Source: Annual Congress 2008 - Various aspects of thoracic oncology Year: 2008 Malignant pleural disease in primary lung cancer Source: Eur Respir Mon; 2009: 44: 318–335 Year: 2009 Tumours of the pleura - Mesothelioma Source: Respipedia Article Year: 2017 Non-malignant pleural disease from asbestos and malignant pleural mesothelioma Source: Eur Respir Monogr 2020; 89: 141-149 Year: 2020 Pleural effusion in patients with IgG4-related disease: new insights from a case series Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Importance of parietal pleural biopsy (PPB) in the diagnosis of etiology of pleural effusion (PE) Source: Eur Respir J 2004; 24: Suppl. 48, 628s Year: 2004 Adenosine deaminase (ADA) in diagnosis of tuberculous pleural effusions in a developing country and region with average incidence of pulmonary tuberculosis Source: Annual Congress 2007 - Immunology and genetics of tuberculosis Year: 2007 Polarized cytokine profiles in the peripheral blood and pleural fluid from the patients with tuberculous pleurisy, pulmonary tuberculosis combined disease, and malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 467s Year: 2004 Pleural effusion in patients with IgG4-related disease: Investigated features and compared to tuberculous pleurisy Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Tumour marker (TM) CA 19-9 in pleural fluid at patients with malignant and paramalignant pleural effusion (PE) Source: Eur Respir J 2001; 18: Suppl. 33, 387s Year: 2001 Pleural and mediastinal diseases Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Pleural and mediastinal diseases Source: HERMES Summer School 2014 - Educational material Year: 2014 Pleural and mediastinal diseases Source: ERS Skills Course 2016 Year: 2016 Pleural and mediastinal diseases Source: ERS Course 2015 Year: 2015